Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-11

Clinical Trial Update: The Effect of Casein Phosphopeptide Amorphous Calcium Phosphate on Affected Dentine [Phase 2]

View source ↗

Summary

Phase 2 trial investigating the effect of casein phosphopeptide amorphous calcium phosphate on affected dentine in dental caries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • casein phosphopeptide-amorphous calcium phosphate (casein phosphopeptide-amorphous calcium phosphate)

Snippet

Sponsor: Hams Hamed Abdelrahman | Conditions: Caries,Dental | Phase 2 | Status: UNKNOWN